Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Bellone

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Cancer Research|April 15, 2010
Concomitant tumor and minor histocompatibility antigen-specific immunity initiate rejection and maintain remission from established spontaneous solid tumorsRodrigo Hess Michelini, Massimo Freschi, Teresa Manzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2020
Iron Induces Cell Death and Strengthens the Efficacy of Antiandrogen Therapy in Prostate Cancer ModelsJessica Bordini, Federica Morisi, Angela Rita Elia, et al.
European Journal of Immunology|December 15, 2004
Peripheral T cell tolerance occurs early during spontaneous prostate cancer development and can be rescued by dendritic cell immunizationElena Degl'Innocenti, Matteo Grioni, Andrea Boni, et al.
Cytokine & Growth Factor Reviews|June 22, 2017
Goals and objectives of the Italian Network for Tumor Biotherapy (NIBIT)Vincenzo Russo, Alberto Amadori, Marco Bregni, et al.
Arthritis and Rheumatism|April 11, 2003
Cellular microchimerism as a lifelong physiologic status in parous women: an immunologic basis for its amplification in patients with systemic sclerosisSamuele E Burastero, Silvia Galbiati, Antonia Vassallo, et al.
Cancer Immunology, Immunotherapy : CII|January 16, 2022
Cancer bio-immunotherapy XVIII annual NIBIT-(Italian network for tumor biotherapy) meeting, October 15-16, 2020Matteo Bellone, Arianna Brevi, Vincenzo Bronte, et al.
Cancer Immunology, Immunotherapy : CII|March 30, 2023
Cancer immunity and immunotherapy beyond COVID-19Matteo Bellone, Arianna Brevi, Vincenzo Bronte, et al.
Cancer Research|June 3, 2004
Nitric oxide confers therapeutic activity to dendritic cells in a mouse model of melanomaCristiana Perrotta, Sestina Falcone, Annalisa Capobianco, et al.
Small (Weinheim an Der Bergstrasse, Germany)|September 17, 2019
Boosting Interleukin-12 Antitumor Activity and Synergism with Immunotherapy by Targeted Delivery with isoDGR-Tagged NanogoldAnna Maria Gasparri, Angelina Sacchi, Veronica Basso, et al.
Blood Advances|July 16, 2021
CD4+ T cells sustain aggressive chronic lymphocytic leukemia in Eμ-TCL1 mice through a CD40L-independent mechanismMatteo Grioni, Arianna Brevi, Elena Cattaneo, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Cancer Research|April 15, 2010
Concomitant tumor and minor histocompatibility antigen-specific immunity initiate rejection and maintain remission from established spontaneous solid tumorsRodrigo Hess Michelini, Massimo Freschi, Teresa Manzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2020
Iron Induces Cell Death and Strengthens the Efficacy of Antiandrogen Therapy in Prostate Cancer ModelsJessica Bordini, Federica Morisi, Angela Rita Elia, et al.
European Journal of Immunology|December 15, 2004
Peripheral T cell tolerance occurs early during spontaneous prostate cancer development and can be rescued by dendritic cell immunizationElena Degl'Innocenti, Matteo Grioni, Andrea Boni, et al.
Cytokine & Growth Factor Reviews|June 22, 2017
Goals and objectives of the Italian Network for Tumor Biotherapy (NIBIT)Vincenzo Russo, Alberto Amadori, Marco Bregni, et al.
Arthritis and Rheumatism|April 11, 2003
Cellular microchimerism as a lifelong physiologic status in parous women: an immunologic basis for its amplification in patients with systemic sclerosisSamuele E Burastero, Silvia Galbiati, Antonia Vassallo, et al.
Cancer Immunology, Immunotherapy : CII|January 16, 2022
Cancer bio-immunotherapy XVIII annual NIBIT-(Italian network for tumor biotherapy) meeting, October 15-16, 2020Matteo Bellone, Arianna Brevi, Vincenzo Bronte, et al.
Cancer Immunology, Immunotherapy : CII|March 30, 2023
Cancer immunity and immunotherapy beyond COVID-19Matteo Bellone, Arianna Brevi, Vincenzo Bronte, et al.
Cancer Research|June 3, 2004
Nitric oxide confers therapeutic activity to dendritic cells in a mouse model of melanomaCristiana Perrotta, Sestina Falcone, Annalisa Capobianco, et al.
Small (Weinheim an Der Bergstrasse, Germany)|September 17, 2019
Boosting Interleukin-12 Antitumor Activity and Synergism with Immunotherapy by Targeted Delivery with isoDGR-Tagged NanogoldAnna Maria Gasparri, Angelina Sacchi, Veronica Basso, et al.
Blood Advances|July 16, 2021
CD4+ T cells sustain aggressive chronic lymphocytic leukemia in Eμ-TCL1 mice through a CD40L-independent mechanismMatteo Grioni, Arianna Brevi, Elena Cattaneo, et al.
Pageof 9